Back to the newspaper
DEVELOPING · Attributed source report · science · World

Trial results posted: A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NULLPEN · Source published 11/17/2026, 12:00:00 AM UTC

ClinicalTrials.gov records the first posting of results for study NCT05394116 on 2026-11-17. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

The source record

National Library of Medicine, National Institutes of Health

Source: ClinicalTrials.gov, National Library of Medicine, United States. Registry entries are filed by trial sponsors; the registry does not verify them.Retrieved 2026-11-17T16:00:25.420Z. Updated on NULLPEN 2026-11-17T16:00:26.496Z.Revision sha256:f8bc72bfa2861e2cef0c9006a143cda6d474058bb970176730a06f3d62f771a1